. Author manuscript; available in PMC: 2022 May 1.

Published in final edited form as: Pediatr Infect Dis J. 2021 May 1;40(5):429–433. doi: 10.1097/INF.0000000000002992

Table 2.

Outcomes following Staphylococcus aureus bacteremia with and without reduced vancomycin susceptibility.

Outcome	Non-RVS N=117 (%)	RVS N=309 (%)	P
Required ICU care	44 (38)	112 (36)	0.80
Required intubation	21 (18)	37 (12)	0.11
Needed surgery	23 (20)	49 (16)	0.37
Hospital length of stay^*	13 (7, 41)	11 (7, 22)	0.22
ICU length of stay^*	0 (0, 13)	0 (0, 5)	0.44
Bacteremia >3 days	31 (26)	85 (28)	0.83
Duration of bacteremia	1 (1, 4)	2 (1, 4)	0.28
Died	7 (6)	21 (7)	0.76
Treatment failure	37 (32)	96 (31)	0.91

median (25^th, 75^th percentiles)